臨床外科65巻11号

2010年10月発行

特集 外科医のための大腸癌の診断と治療 6．Stage Ⅳ大腸癌の治療方針

肝転移を伴うStage Ⅳ大腸癌の治療方針

著者： 小林宏寿¹ 榎本雅之¹ 樋口哲郎¹ 植竹宏之¹ 飯田聡¹ 石川敏昭¹ 石黒めぐみ¹ 加藤俊介¹ 小野宏晃¹ 菊池章史¹ 山内慎一¹ 杉原健一¹

所属機関： ¹東京医科歯科大学大学院腫瘍外科学

ページ範囲：P.402 - P.407

■肝転移を有するStage IV大腸癌の治療成績は，現時点では原発巣ならびに肝転移に対する外科的切除術が最も良い．

■発見時に切除不可能な肝転移を有する場合でも，全身化学療法によって切除可能となることがある．

■大腸癌肝転移に対しては，症例に応じて外科的切除以外にも，全身化学療法，肝動注療法，熱凝固療法などが治療に用いられる．

参考文献

1）Kobayashi H, Mochizuki H, Sugihara K, et al：Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer：a multicenter study. Surgery 141：67-75, 2007

2）Weiss L, Grundmann E, Torhorst J, et al：Haematogenous metastatic patterns in colonic carcinoma：an analysis of 1541 necropsies. J Pathol 150：195-203, 1986

3）Scheele J, Stangl R, Altendorf-Hofmann A：Hepatic metastases from colorectal carcinoma：impact of surgical resection on the natural history. Br J Surg 77：1241-1246, 1990

4）Wade TP, Virgo KS, Li MJ, et al：Outcomes after detection of metastatic carcinoma of the colon and rectum in a national hospital system. J Am Coll Surg 182：353-361, 1996

5）大腸癌研究会（編）：大腸癌治療ガイドライン，医師用2009年版．金原出版，2009

6）Stillwell AP, Buettner PG, Ho YH：Meta-analysis of survival of patients with Stage Ⅳ colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg 34：797-807, 2010

7）Poultsides GA, Servais EL, Saltz LB, et al：Outcome of primary tumor in patients with synchronous Stage Ⅳ colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol 27：3379-3384, 2009

8）Iwatsuki S, Esquivel CO, Gordon RD, et al：Liver resection for metastatic colorectal cancer. Surgery 100：804-810, 1986

9）Gayowski TJ, Iwatsuki S, Madariaga JR, et al：Experience in hepatic resection for metastatic colorectal cancer：analysis of clinical and pathologic risk factors. Surgery 116：703-710；discussion 10-11, 1994

10）Yamamoto J, Sugihara K, Kosuge T, et al：Pathologic support for limited hepatectomy in the treatment of liver metastases from colorectal cancer. Ann Surg 221：74-78, 1995

11）Jaeck D, Pessaux P：Bilobar colorectal liver metastases：treatment options. Surg Oncol Clin N Am 17：553-568, ix, 2008

12）Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer：long-term results. Ann Surg 231：487-499, 2000

13）Cady B, Jenkins RL, Steele GD, Jr, et al：Surgical margin in hepatic resection for colorectal metastasis：a critical and improvable determinant of outcome. Ann Surg 227：566-571, 1998

14）Kokudo N, Miki Y, Sugai S, et al：Genetic and histological assessment of surgical margins in resected liver metastases from colorectal carcinoma：minimum surgical margins for successful resection. Arch Surg 137：833-840, 2002

15）Kokudo N, Sato T, Seki M, et al：Hepatic lymph node involvement in resected cases of liver metastases from colorectal cancer. Dis Colon Rectum 42：1285-1290；discussion 90-91, 1999

16）Capussotti L, Ferrero A, Vigano L, et al：Major liver resections synchronous with colorectal surgery. Ann Surg Oncol 14：195-201, 2007

17）Chua HK, Sondenaa K, Tsiotos GG, et al：Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 47：1310-1316, 2004

18）de Santibanes E, Lassalle FB, McCormack L, et al：Simultaneous colorectal and hepatic resections for colorectal cancer：postoperative and longterm outcomes. J Am Coll Surg 195：196-202, 2002

19）Scheele J：Hepatectomy for liver metastases. Br J Surg 80：274-276, 1993

20）Adam R, Wicherts DA, de Haas RJ, et al：Patients with initially unresectable colorectal liver metastases：is there a possibility of cure? J Clin Oncol 27：1829-1835, 2009

21）Bismuth H, Adam R, Levi F, et al：Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224：509-520；discussion 20-22, 1996

22）Masi G, Cupini S, Marcucci L, et al：Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer. Ann Surg Oncol 13：58-65, 2006

23）Kerr DJ, McArdle CS, Ledermann J, et al：Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases：a multicentre randomised trial. Lancet 361：368-373, 2003

24）Lorenz M, Muller HH：Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 18：243-254, 2000

25）Kemeny NE, Niedzwiecki D, Hollis DR, et al：Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer：a randomized trial of efficacy, quality of life, and molecular markers（CALGB 9481）. J Clin Oncol 24：1395-1403, 2006

26）Mocellin S, Pilati P, Lise M, et al：Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer：the end of an era? J Clin Oncol 25：5649-5654, 2007

27）Wong SL, Mangu PB, Choti MA, et al：American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 28：493-508, 2010

28）Abitabile P, Hartl U, Lange J, et al：Radiofrequency ablation permits an effective treatment for colorectal liver metastasis. Eur J Surg Oncol 33：67-71, 2007

29）Stippel DL, Bohm S, Beckurts KT, et al：Intraoperative radiofrequency ablation using a 3D navigation tool for treatment of colorectal liver metastases. Onkologie 25：346-350, 2002